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Abstract 
BACKGROUND: Lung volume reduction surgery (LVRS) was introduced to alleviate clinical conditions in selected 
patients with heterogenous emphysema. Clarifying the most suitable patients for LVRS remained unclear. 
AIM: This study was undertaken to specifically analyze the preoperative factor affecting to LVRS. 
METHODS: The prospective study was conducted at 103 Military Hospital between July 2014 and April 2016. 
Severe heterogenous emphysema patients were selected to participate in the study. The information, spirometry, 
and body plethysmographic pulmonary function tests in 31 patients who underwent LVRS were compared with 
postoperative outcomes (changing in FEV1 and CAT scale). 
RESULTS: Of the 31 patients, there was statistically significant difference in the outcome of functional capacity, 
lung function between two groups (FEV1 ≤ 50% and > 50%) (∆FEV1: 22.46 vs 18.32%; p = 0.042. ∆CAT: 6.85 vs 
5.07; p = 0.048). Changes of the FEV1 and CAT scale were no statistically significant differences in three groups 
residual volume. Patients with total lung capacity < 140% had more improved than others (∆FEV1: 23.81 vs 
15.1%; p = 0.031). 
CONCLUSION: Preoperative spirometry and body plethysmographic pulmonary function tests were useful 
measures to selected severe heterogenous emphysema patients for LVRS. Patients with FEV1 ≤ 50%, TLC in the 
range of 100-140% should be selected. 
 
 
 
 
 
Introduction 
 
Emphysema is an incurable with high 
prevalence in adults worldwide [1]. It has been treated 
according to the guideline of GOLD [1]. In severe 
emphysema, treatment included lung volume 
reduction (LVR) therapy in accordance with medical 
treatment to maximize clinically meaningful benefits 
[2]. Three common LVR therapies were surgery, 
endobronchial valve, endobronchial coil but each 
therapy was considered to feasible in selected 
patients [2]. LVR coil treatment for bilateral lung 
emphysema resulted in good safety and sustained 
outcomes with significant clinical improvements [3]. 
Endobronchial valves for intact interlobar fissures in 
emphysema improved significantly in lung function [4]. 
In severe emphysema with selected cases, LVRS has 
been showed good outcomes [5]. It was more widely 
used in the treatment of emphysema [6], [7] with 
selection criteria depended on characteristics of 
diseases and patients. In most series, LVRS was 
chosen for patients who had heterogenous 
emphysema with upper lobes occupying almost that 
present in about 25 percent of moderate-to-severe 
patients [8]. Thus, the benefit of LVRS did not 
generate to all patients. The reason behind this is that 
LVRS is suitable for selecting patients. It showed 
effective in patients with bilateral upper lobe 
heterogeneous emphysema but did not use for the 
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arbitrary patient [9]. The NETT study pointed out the 
condition that benefits for LVRS were heterogenous 
disease, low baseline exercise capacity, and upper 
lobe predominance [5]. Beyond the NETT selection 
criteria, more patients with different conditions also 
can be suitable for LVRS [10]. To get successful 
outcomes, patient selection and preoperation care 
were crucial [11]. 
Clarifying the most suitable patients for LVRS 
remained unclear. This study, therefore, was 
undertaken to specifically analyze the preoperative 
factor affecting to this surgery. This contributed to 
further refine the selection criteria when LVRS is 
performed for patients with severe heterogeneous 
emphysema. 
 
 
Materials and Method 
 
Patients  
This prospective study was conducted at 103 
Military Hospital between July 2014 and April 2016. 
Severe emphysema patients were selected to 
participate in the study. Patients had inclusion and no 
exclusion criteria underwent LVRS. Selecting criteria 
for LVRS showed in Table 1. Indications for LVRS 
included clinical symptom (severe dyspnea), 
spirometry (airflow obstruction), and image of 
emphysema (on chest radiography and computed 
tomographic (CT) scanning). Any history of childhood 
asthma/atopy, bronchiectasis, inhalation injury or 
drug-caused bronchiolitis was excluded from the 
study. 
Table 1: Selecting criteria for LVRS 
Inclusion criteria 
Age 40-80 years  
Severe, heterogeneous emphysema, at CT 
Forced expiratory volume in one second ≤ 60% but > 20% 
Residual volume ≥ 150% 
Total lung capacity ≥ 100% 
Resting room PaO2 > 45 mmHg 
Quit smoking since at least 4 months 
 
 
Evaluation before surgery 
Six months before performing surgery, all 
patients stopped cigarettes and six-week before that, 
a pulmonary rehabilitation program for all patients was 
required. The final routine evaluation for surgery was 
managed without abnormal findings [12], [13], [14]. 
Patients had any contraindications to surgery at that 
time were excluded such as severe concurrent 
diseases, pleural scarring, pulmonary-artery 
hypertension or; using inappropriate glucocorticoids; 
and failure to complete the requirements above before 
surgery [5]. Dividing patients into two groups: group 1: 
17 patients with FEV1 ≤ 50% before surgery and 
group 2: 14 patients with FEV1 > 50% before surgery. 
Surgical Technique 
Choosing a surgical technique depended on 
the condition of patients [15]. After placing lateral 
decubitus position, general anesthesia was used with 
provision for single-lung ventilation. Unilateral 
thoracoscopic surgery was performed in 6 patients 
and video-assisted thoracoscopic surgery (VATS) was 
performed in 25 patients to reduce lung volume. 
Approximately about 30% of the lung (estimating 30-
40 grams) was resected (Figure 1). 
 
Figure 1: Lung resection in lung volume reduction surgery (LVRS) 
 
Follow-up 
Three months after surgery, change FEV1 
and CAT scale were compared to evaluate the 
valuable index for LVRS. 
 
Statistical Analysis 
Using SPSS ver. 20.0 software (IBM 
Corporation, Armonk, NY, USA) to analyze. 
Descriptive analysis was presented as a means ± 
standard deviations. Using Student’s paired t-test to 
compare with p-value that considered statistically 
significant was < 0.05. 
 
 
Results 
 
Patients’ characteristics  
Thirty-one patients participated in and 
completed the study. There were no hospital deaths in 
all group, no patient died three months after surgery. 
Preoperative patient’s characteristics showed in Table 
2. Functional capacity was assessed by the COPD 
Assessment Test scale (CAT). Spirometry 
demonstrated FEV1, TLC, and RV. All FEV1 values 
were less than normal with the mean was 49.46 
percent and the lowest value was 23 percent. TLC 
was only minimally elevated with the value was more 
than 100 percent. Whereas RV was significantly 
elevated with patients, the value was more than 150 
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percent in all patients and the maximum value was 
479 percent. 
Table 2: Preoperative characteristics 
Characteristics Value 
Age (years) 62.13 ± 5.77 
Gender (M/F) 31 / 0 
CAT scale 18.42 ± 5.57 
Forced expiratory volume in one second (FEV1) 
Mean (%) 49.46 ± 12.22 
≤ 50% 17 
> 50% 14 
Geansler index (%) 58.0 ± 11.93 
Total lung capacity (TLC) 
Mean 137.29 ± 23.83 
Range 106-227 
Residual volume (RV) 
Mean 219.25 ± 72.14 
Range 153-479 
 
 
Postoperative outcome 
After LVRS, FEV1 significantly increased as a 
whole. Two groups were compared before surgery 
and three months after surgery. Detail information 
showed in Table 3. Changes in FEV1 and CAT scale 
in group 1 was 22.46% and 6.85. Group 1 had more 
improved than group 2. 
Table 3: Comparison between two groups 
Variable 
∆FEV1 
Mean (95% CI) 
∆CAT 
Mean (95% CI) 
FEV1   
≤ 50% 22.46 (7.75 – 37.16) 6.85 (5.84 – 7.4) 
> 50% 18.32 (7.55 – 29.10) 5.07 (3.36 – 6.77) 
 Significance p = 0.042 p = 0.048 
RV   
 150-200% 19.81 (7.33 – 32.28) 5.3 (3.81 – 6.79) 
 200-250% 29.75 (8.87 – 50.64) 7 (5.11 – 8.88) 
> 250% 16.37 (9.90 – 42.73) 6.4 (3.97 – 8.82) 
 Significance p = 0.123 p = 0.19 
TLC   
100 – 140% 23.81 (10.21 – 37.41) 5.76 (4.45 – 7.06) 
> 140% 15.10 (7.23 – 22.97) 6.27 (4.68 – 7.86) 
 Significance p = 0.031 p = 0.6 
 
 
Patient with a preoperative RV less than 
200%, the mean of change FEV1 was 19.81% and 
change of CAT scale was 5.3. The FEV1 increased 
29.75% for patients with RV from 200 to 250% 
compared with 16.37% for patients with RV greater 
than 250% (p > 0.05). Preoperative, 10 patients had 
TLC than 100% and less than 140% of the predicted 
value. Their postoperative mean FEV1 increased by 
23.81% compared with 15.10% changes in patients 
with preoperative TLC greater than 140% of the 
predicted value. 
 
 
Discussion 
 
LVRS showed more benefits in the patient 
with severe heterogeneous emphysema in terms of 
many clinical outcomes [16]. One of the key factors to 
achieve these benefits is selecting the right 
candidates for surgery. It includes general risk and the 
emphysema characteristics regarding morphology and 
function. From morphological perspectives, the 
diseased regions in emphysema were detected by 
computed tomography densitometry [17]. It helped to 
target and treat with segmental approach that was 
promise method to improve efficacy and safety 
outcomes.[18] But from functional perspectives, many 
questions for the selection of ideal candidates for 
LVRS remained unclear [19]. 
The core concept of LVRS is resecting non-
functional areas to allow improving functional areas 
[20]. This is why it does not benefit in the case of 
patients who had airway obstruction. In our study, we 
reasoned that spirometry and body plethysmographic 
pulmonary function tests would be valuable factors in 
selecting patients for LVRS. In patients with highly 
airway resistance, the expiratory flow seems to not 
improving in response to LVRS [21], [22]. Vice versa, 
lung function improved when performing LVRS in 
patients with less airway resistance [23], [24], [25], 
[26]. In line with the lung function test, functional 
capacity assessed by CAT that presented the 
limitation of activity with moderate-to-severe level [27], 
[28]. It is valuable indicator to fully evaluate patients 
after LVRS. 
In this study, the measures of clinical 
outcomes include changing in FEV1 and changing in 
CAT scale. After LVRS, the apparent improvement in 
FEV1 and CAT scale has improved quality of life, 
reduced dyspnea, and increased physical activities. 
The improvement in clinical outcomes following LVRS 
best correlates with the activity of respiratory muscle. 
Patients with FEV1 ≤ 50% have relatively severe 
obstruction. Meanwhile, patients with FEV1 > 50% of 
the degree of dyspnea and moderate obstruction, and 
the improvement was not as obvious as the FEV1 
group under 50%. However, the patients who have 
too low FEV1 face a high risk of complications after 
surgery, especially those with FEV1 below 20% [29]. 
In addition, TLC is also a factor in recommending 
patients for LVRS. In our study, the results showed 
that TLC patients in the range of 100-140% given 
better postoperative results than patients with TLC 
above 140%. High TLC patients exhibit severe 
emphysema. With these patients, the lung 
parenchyma was less elastic, reducing perfusion, so 
LVRS recovery was also worse than that of the small 
TLC group. Our data showed that it was reasonable to 
perform LVRS on the patients with FEV1 ≤ 50 and 
TLC < 140 percent of the predicted value. These 
findings will optimize evaluating patients with 
heterogeneous emphysema who consider for LVRS. 
In conclusion, preoperative spirometry and 
body plethysmographic pulmonary function tests were 
useful measures to selected severe heterogenous 
emphysema patients for LVRS. Patients with FEV1 ≤ 
50%, TLC in the range of 100-140% should be 
selected. 
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